Increased cyclooxygenase-2 expression in large flat colorectal tumors (laterally spreading tumors)

Journal of Gastroenterology

Volumn 38, Issue 1, 2003, Pages 69-73

  Yamashita, Kentaro ^a   Arimura, Yoshiaki ^a   Shimizu, Haruo ^a   Takahashi, Hiroaki ^a   Endo, Takao ^a   Imai, Kohzoh ^a   Yamano, Hiroo ^b  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

^b AKITA RED CROSS HOSPITAL   (Japan)

Author keywords

Colorectal neoplasm; Cyclooxygenase 2; Laterally spreading tumor; Nonsteroidal anti inflammatory drugs

Indexed keywords

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CHEMOPROPHYLAXIS; COLORECTAL TUMOR; CONTROLLED STUDY; DYSPLASIA; EPITHELIUM CELL; FEMALE; GASTROINTESTINAL ENDOSCOPY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEYDIG CELL; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZATION; TREATMENT PLANNING; TUMOR VOLUME;

COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 0037289459     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350300008     Document Type: Article

References (26)

1. Kudo S. Endoscopic mucosal resection of flat and depressed types of early colorectal cancer. Endoscopy 1993;25:455-61.
2. Yoshikane H, Hidano H, Sakakibara A, Mori S, Takahashi Y, Niwa Y, et al. Endoscopic resection of laterally spreading tumours of the large intestine using a distal attachment. Endoscopy 1999; 31:426-30.
3. Tanimoto T, Tanaka S, Haruma K, Yoshihara M, Sumii K, Kajiyama G, et al. Growth patterns in various macroscopic types of noninvasive intramucosal colorectal carcinoma with special reference to apoptosis and cell proliferation. Dis Colon Rectum 1998;41:1376-84.
4. Minamoto T, Sawaguchi K, Mai M, Yamashita N, Sugimura T, Esumi H. Infrequent K-ras activation in superficial-type (flat) colorectal adenomas and adenocarcinomas. Cancer Res 1994; 54:2841-4.
5. Yamagata S, Muto T, Uchida Y, Masaki T, Sawada T, Tsuno N, et al. Lower incidence of K-ras codon 12 mutation in flat colorectal adenomas than in polypoid adenomas. Jpn J Cancer Res 1994; 85:147-51.
6. Olschwang S, Slezak P, Roze M, Jaramillo E, Nakano H, Koizumi K, et al. Somatically acquired genetic alterations in flat colorectal neoplasias. Int J Cancer 1998;77:366-9.
7. Sano H, Kawahito Y, Wilder RL, Hashiramoto A, Mukai S, Asai K, et al. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 1995;55:3785-9.
8. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994;107:1183-8.
9. Kargman SL, O'Neill GP, Vickers PJ, Evans JF, Mancini JA, Jothy S. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res 1995;55:2556-9.
10. Kutchera W, Jones DA, Matsunami N, Groden J, McIntyre TM, Zimmerman GA, et al. Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. Proc Natl Acad Sci U S A 1996;93:4816-20.
11. Shattuck-Brandt RL, Lamps LW, Heppner Goss KJ, DuBois RN, Matrisian LM. Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms. Mol Carcinog 1999;24:177-87.
12. Hao X, Bishop AE, Wallace M, Wang H, Willcocks TC, Maclouf J, et al. Early expression of cyclo-oxygenase-2 during sporadic colorectal carcinogenesis. J Pathol 1999;187:295-301.
13. Chapple KS, Cartwright EJ, Hawcroft G, Tisbury A, Bonifer C, Scott N, et al. Localization of cyclooxygenase-2 in human sporadic colorectal adenomas. Am J Pathol 2000:156:545-53.
14. Japanese Society for Cancer of the Colon and Rectum. General rules for clinical and pathological studies on cancer of the colon, rectum and anus. 6th Ed. Tokyo: Kanehara; 1998.
15. Thun MJ, Namboodiri MM, Heath CW. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 1991;83:1593-6.
16. Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Stolley PD, Shapiro S. A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst 1991;83:355-8.
17. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Willett WC. Aspirin use and the risk for colorectal cancer and adenomas in male health professionals. Ann Intern Med 1994;121: 241-6.
18. Waddell WR, Loughry RW. Sulindac for polyposis of the colon. J Surg Oncol 1983;24:83-7.
19. Labayle D, Fischer D, Vielh P, Drouhin F, Pariente A, Bories C, et al. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 1991;101:635-9.
20. Giardiello FM, Hamilton SR, Krush AJ, Piantadosi S, Hylind LM, Celano P, et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 1993; 328:1313-6.
21. Elder DJE, Paraskeva C. COX-2 inhibitors for colorectal cancer. Nature Med 1998;4:392-3.
22. Williams CS, Mann M, DuBois RN. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 1999;18: 7908-16.
23. Sinicrope FA, Lemoine M, Xi L, Lynch PM, Cleary KR, Shen Y, et al. Reduced expression of cyclooxygenase 2 proteins in hereditary nonpolyposis colorectal cancers relative to sporadic cancers. Gastroenterology 1999;117:350-8.
24. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996;87:803-9.
25. Bamba H, Ota S, Kato A, Adachi A, Itoyama S, Matsuzaki F. High expression of cyclooxygenase-2 in macrophages of human colonic adenoma. Int J Cancer 1999;83:470-5.
26. Karnes WE Jr, Shattuck-Brandt R, Burgart LJ, Dubios RN, Tester DJ, Cunningham JM, et al. Reduced COX-2 protein in colorectal cancer with defective mismatch repair. Cancer Res 1998;58:5473-7.